Triomics has secured $22 million in new funding to support the deployment of AI solutions tailored for oncology in cancer treatment centers. The company aims to advance AI-driven methods for improving cancer care and operational efficiency within these facilities.
An audit by Ontario's auditor general has found significant accuracy issues with AI-powered medical scribes. The technology, used to automate clinical note-taking, was found to generate errors including fabricated information, raising concerns about patient safety.
Medicare has unveiled a new payment model designed to facilitate the integration of artificial intelligence in healthcare services. Although the change holds significant implications for technology and healthcare companies, it has drawn limited attention from the broader tech sector.
TeiaCare, an Italian developer of AI-driven care-monitoring solutions for healthcare facilities, has raised €7 million in a new funding round led by P101 SGR. The company plans to accelerate the development of its proprietary platform and expand into new European markets, focusing initially on France and Spain.
A new artificial intelligence tool has shown remarkable accuracy in predicting the spread of cancer, according to recent research. The technology promises to enhance diagnostic precision and support clinical decision-making in oncology.
AI-powered medical triage systems are increasingly used to prioritise patient care, but concerns about potential bias and blind spots persist. Identifying and mitigating these risks is critical for ensuring safe and equitable patient outcomes. This article examines methods to detect and address bias in AI medical triage tools.
SpendRule, a startup focused on healthcare spending management, has raised $2 million in funding and emerged from stealth. The company's platform aims to help hospitals monitor and optimize their expenditures, addressing efficiency challenges in the sector.
Artificial intelligence is increasingly being applied in palliative care for blood cancer, offering new possibilities in symptom management and decision-making support. Emerging solutions leverage large language models and data-driven approaches to improve patient outcomes and personalize therapy. The technology is poised to transform the standard of care, while raising questions about ethics and implementation.
Artificial intelligence is playing an increasingly significant role in improving patient care and developing personalized treatment plans. Through advanced algorithms and data analysis, AI helps clinicians make more accurate diagnoses and tailor therapies to individual patients' needs.
Healthcare providers are increasingly exploring artificial intelligence to enhance palliative oncology, aiming to improve decision-making and patient outcomes. Ensuring the safe and ethical deployment of these AI tools is critical, with a focus on transparency, accountability, and patient-centered care.
Stay informed with curated insights delivered weekly to your inbox.